Related Experiment Video
Updated: Sep 20, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.9K
SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
Adekunle Sanyaolu1, Aleksandra Marinkovic2, Stephanie Prakash2
1Department of Public Health, Federal Ministry of Health, Abuja 0000, Nigeria. sanyakunle@hotmail.com.
World Journal of Virology
|June 6, 2022
Summary
The Omicron variant of SARS-CoV-2 shows significant mutations, potentially increasing transmissibility and immune evasion. Further research is needed for definitive clinical and immunological data on this concerning variant.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The emergence of SARS-CoV-2 variants poses a significant global health challenge.
- Omicron (B.1.1.529) is a highly mutated variant of concern with potential implications for transmissibility and vaccine effectiveness.
Purpose of the Study:
- To provide a comprehensive overview of the SARS-CoV-2 Omicron variant.
- To analyze the potential impact of Omicron's mutations on transmissibility, severity, and immune escape.
Main Methods:
- Literature review of major scientific databases.
- Extrapolation of data based on known mutations and existing research.
Main Results:
- Omicron exhibits extensive mutations, comparable to previous variants of concern.
- Preliminary indications suggest potential for increased transmissibility and partial resistance to vaccine-induced immunity.
Conclusions:
- Omicron represents a significantly altered SARS-CoV-2 strain requiring further investigation.
- Definitive immunological and clinical data are pending, but mutations suggest potential for altered disease dynamics.
More Related Videos
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
16.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.0K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K